ストックスクリーナーアプリを入手
290.86
3.04%
8.58
前日終値:
$282.28
開ける：
$282.52
24時間の取引高:
955.98K
Relative Volume:
0.68
時価総額：
$47.53B
収益：
$2.86B
当期純損益:
$780.66M
株価収益率:
61.62
EPS:
4.72
ネットキャッシュフロー:
$1.19B
1週間 パフォーマンス:
+3.65%
1か月 パフォーマンス:
+1.98%
6か月 パフォーマンス:
+28.82%
1年 パフォーマンス:
+47.60%
1日の値動き範囲:
$280.97
$291.26
1週間の範囲:
$278.10
$291.26
52週間の値動き範囲:
$196.09
$296.72
Veeva Systems Inc Stock (VEEV) Company Profile
VEEV を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
VEEV
Veeva Systems Inc
|
290.86 | 46.10B | 2.86B | 780.66M | 1.19B | 4.72 |
|
TEM
Tempus Ai Inc
|
80.52 | 13.63B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
67.74 | 12.35B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
89.82 | 7.74B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
36.24 | 6.32B | 906.14M | -52.62M | 89.62M | -0.3621 |
Veeva Systems Inc Stock (VEEV) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-05-29 | 繰り返されました | Needham | Buy |
| 2025-01-23 | ダウングレード | Goldman | Buy → Sell |
| 2024-12-20 | 開始されました | Stephens | Overweight |
| 2024-12-04 | 開始されました | Mizuho | Outperform |
| 2024-11-19 | 開始されました | Scotiabank | Sector Perform |
| 2024-10-08 | 開始されました | Exane BNP Paribas | Outperform |
| 2024-08-27 | 繰り返されました | Citigroup | Buy |
| 2024-07-09 | 開始されました | BTIG Research | Buy |
| 2023-10-25 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2023-10-13 | 開始されました | Jefferies | Buy |
| 2023-06-28 | ダウングレード | Morgan Stanley | Equal-Weight → Underweight |
| 2023-06-01 | アップグレード | Guggenheim | Neutral → Buy |
| 2023-03-17 | ダウングレード | Truist | Buy → Hold |
| 2023-02-23 | ダウングレード | Guggenheim | Buy → Neutral |
| 2023-01-04 | アップグレード | Barclays | Equal Weight → Overweight |
| 2022-12-06 | 開始されました | Cowen | Market Perform |
| 2022-12-02 | 繰り返されました | Needham | Buy |
| 2022-10-31 | 開始されました | Wells Fargo | Equal Weight |
| 2022-10-19 | アップグレード | JP Morgan | Underweight → Neutral |
| 2022-09-16 | 開始されました | KeyBanc Capital Markets | Overweight |
| 2022-07-27 | 開始されました | Oppenheimer | Outperform |
| 2022-06-23 | 開始されました | Goldman | Buy |
| 2022-06-21 | 再開されました | Guggenheim | Buy |
| 2022-03-03 | ダウングレード | BofA Securities | Buy → Neutral |
| 2022-01-28 | 開始されました | Truist | Buy |
| 2022-01-07 | ダウングレード | Stephens | Overweight → Equal-Weight |
| 2022-01-06 | アップグレード | SVB Leerink | Mkt Perform → Outperform |
| 2021-12-16 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2021-10-01 | 再開されました | Stifel | Buy |
| 2021-09-02 | 繰り返されました | BofA Securities | Buy |
| 2021-09-02 | 繰り返されました | JMP Securities | Mkt Outperform |
| 2021-09-02 | 繰り返されました | Needham | Buy |
| 2021-09-02 | 繰り返されました | UBS | Neutral |
| 2021-07-21 | 開始されました | Cowen | Outperform |
| 2021-03-31 | アップグレード | UBS | Sell → Neutral |
| 2021-01-07 | 再開されました | KeyBanc Capital Markets | Overweight |
| 2020-12-09 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2020-10-14 | 再開されました | UBS | Sell |
| 2020-08-28 | 繰り返されました | Needham | Buy |
| 2020-07-23 | 開始されました | FBN Securities | Outperform |
| 2020-07-07 | 開始されました | Stephens | Overweight |
| 2020-06-08 | 開始されました | Citigroup | Buy |
| 2020-05-29 | 繰り返されました | Needham | Buy |
| 2020-04-13 | 開始されました | SVB Leerink | Mkt Perform |
| 2020-02-19 | 開始されました | Robert W. Baird | Outperform |
| 2020-02-14 | 開始されました | Piper Sandler | Overweight |
| 2020-01-13 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2019-11-27 | 繰り返されました | Canaccord Genuity | Hold |
| 2019-09-26 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2019-08-28 | 繰り返されました | Needham | Buy |
| 2019-06-07 | 開始されました | Goldman | Neutral |
| 2019-05-30 | 繰り返されました | BofA/Merrill | Buy |
| 2019-05-30 | アップグレード | Stephens | Equal-Weight → Overweight |
| 2019-05-24 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2019-04-17 | 繰り返されました | Needham | Buy |
| 2019-02-27 | 繰り返されました | Needham | Buy |
すべてを表示
Veeva Systems Inc (VEEV) 最新ニュース
Veeva Systems Inc. (VEEV) is Attracting Investor Attention: Here is What You Should Know - sharewise.com
Veeva Systems' Strategic Legal Resolution with IQVIA and Its Implications for Cloud CRM in Life Sciences - AInvest
Veeva Systems Hits $270M Trading Volume at No 387 Rank as Shares Dip 0.12% Amid Barclays Buy Rating - AInvest
Veeva Systems Q2 Results Likely In-Line to Better, Maintain H2 Outlook, Truist Says - MarketScreener
Truist Raises Price Target on Veeva Systems to $268 From $230, Keeps Hold Rating - MarketScreener
Recovery Signals Appearing in Veeva Systems Inc. Charts2025 Stock Rankings & AI Powered Buy/Sell Recommendations - newsyoung.net
Veeva : The Path to Data-Driven Quality Management - MarketScreener
Traders Consider Averaging Down in Veeva Systems Inc.2025 AllTime Highs & Daily Stock Momentum Reports - classian.co.kr
Veeva Systems and IQVIA Settle Litigation, Announce Partnership - MSN
Veeva's 0.8% Rally on 341st-Ranked $290M Volume as Legal Spat with IQVIA Turns into Global Partnership - AInvest
IQVIA Shares Slide 0.1% on $210M Trade Volume Ranks 459th as Landmark Veeva Partnership Resolves Legal Disputes and Unleashes AI-Driven Synergies - AInvest
Veeva Systems And IQVIA End Feud, Clearing The Way Forward - Finimize
IQVIA, Veeva Forge Long-Term Clinical and Commercial Partnerships - Medical Product Outsourcing
Veeva Systems: A Top Growth Stock for Long-Term Investors - AInvest
Veeva Systems, IQVIA Dispute Resolution Clears Investor Concerns Over CRM Data Risk: Oppenheimer - AInvest
Veeva Systems, IQVIA Dispute Resolution Removes Investor Concerns Around CRM Data Risk, Oppenheimer Says - MarketScreener
Is Veeva Systems Inc. Forming a Consolidation BasePortfolio Return Summary & Fast Exit/Entry Strategy Plans - newsyoung.net
Why Veeva Systems (VEEV) is a Top Growth Stock for the Long-Term - Yahoo Finance
Veeva and IQVIA Unveil Global Clinical Partnership as Trading Volume Surges 52.22% to 259th Rank - AInvest
IQVIA and Veeva’s Strategic Alliance Spikes Trading Volume 41.85% as Stock Jumps into Top 500 List - AInvest
Life Sciences Data Rivals Settle Trade Secrets Battle - Law360
Healthcare Triangle, Inc. shares rise 1.21% after-hours following IQVIA and Veeva's global partnership announcement. - AInvest
IQVIA and Veeva Form Long-term Partnerships, Resolve All Disputes - AInvest
Iqvia and Veeva Form Global Partnership, Settle Legal Disputes - AInvest
Veeva Systems and IQVIA settle litigation with mutual data access agreements By Investing.com - Investing.com South Africa
Veeva Systems and IQVIA settle litigation with mutual data access agreements - Investing.com Australia
IQVIA, Veeva Announce Long-term Clinical & Commercial Partnerships - Contract Pharma
IQVIA and Veeva Announce Long-term Clinical and Commercial Partnerships and Resolution of All Disputes - Veeva
IQVIA and Veeva Announce Long-term Clinical and Commercial Partnerships and Resolution of All Disputes | VEEV Stock News - GuruFocus
IQVIA, Veeva announce global clinical and commercial partnerships. - AInvest
IQVIA and Veeva Announce Long-term Clinical and Commercial Partnerships - AInvest
Should You Invest in Veeva (VEEV) Based on Bullish Wall Street Views? - MSN
Veeva Systems Inc. (NYSE:VEEV) Q3 2025 Earnings Call Transcript - MSN
Is Veeva Systems Inc. stock risky to hold now2025 Year in Review & Reliable Entry Point Alerts - thegnnews.com
Veeva Systems Rises 2.05% on $230M Volume (Rank 440) as 16.7% Revenue Growth and Institutional Buys Outpace Insider Sales - AInvest
Is Veeva Systems Inc. stock suitable for long term investing2025 Pullback Review & Consistent Profit Trade Alerts - 선데이타임즈
What Technical Tools Say About Veeva Systems Inc. RecoveryJuly 2025 Trade Ideas & Technical Entry and Exit Tips - newsyoung.net
Veeva to Release Fiscal 2026 Second Quarter Results on August 27, 2025 - 富途牛牛
Veeva Systems (VEEV) Exceeds Market Returns: Some Facts to Consider - sharewise.com
Veeva Systems Inc.'s (NYSE:VEEV) Stock's On An Uptrend: Are Strong Financials Guiding The Market? - 富途牛牛
Veeva Systems (VEEV) Declines More Than Market: Some Information for Investors - MSN
Reasons to Add Veeva Systems Stock to Your Portfolio for Now - MSN
Veeva Systems Shares Dip 0.55% as Trading Volume Surges 60% to 310th Rank - AInvest
Reasons To Add Veeva Systems Stock To Your Portfolio For Now - Barchart.com
Research Shows Medtechs Prioritizing Site Collaboration and Data Quality - Veeva
Veeva Systems shares rise 1.16% premarket after announcing findings from the 2025 Veeva MedTech Clinical Benchmark. - AInvest
Research Shows Medtechs Prioritizing Site Collaboration And Data Quality - Barchart.com
eClinical Solutions Market Key Players AnalysisMedidata, Veeva Systems, Iqvia Inc., Icon Plc, Signant Health. - openPR.com
Veeva Systems Dips on 469th-Ranked Volume as Institutions Boost Holdings Amid Insider Share Sales - AInvest
2 Reasons to Watch VEEV and 1 to Stay Cautious - ca.finance.yahoo.com
Veeva Systems Inc. (VEEV) Is a Trending Stock: Facts to Know Before Betting on It - MSN
Veeva Systems Inc (VEEV) 財務データ
収益
当期純利益
現金流量
EPS
4.97%
1.36%
大文字化:
|
ボリューム (24 時間):